Exploratory Interventional Study of Prognostic Serum Biomarkers of Cancer Progression

Clinical trial NCT05426317 · UNKNOWN

Trial details

NCT number: NCT05426317
Sponsor: University Hospital, Clermont-Ferrand
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Melanoma Non Small Cell Lung Cancer Renal Cancer

Start date: 2022-02-10
Primary completion: 2024-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.